Johnson & Johnson MedTech announced today that it launched new variable angle optimized locking technology (VOLT) plating ...

Clarius Group LLC decided to double down on Johnson & Johnson stock this past quarter, padding its portfolio with an ...

Multiple myeloma accounts for 15 per cent of all blood cancers and in recent years, its prevalence has risen sharply and is ...

Wall Street stocks finished flat on Wednesday after the Federal Reserve sounded a more hawkish tone than expected, while ongoing geopolitical uncertainty in the Middle East kept risk appetite in check ...

A Suffolk County jury has awarded $8 million in favor of Janice Paluzzi, a Massachusetts woman who developed mesothelioma ...

A Steady Hand for Choppy Waters Dividend stocks are a cornerstone for savvy investors seeking stability and income, especially amid the Middle East turmoil and uncertainty clouding Federal Reserve ...

While access to capital funding remains elusive for many biotechs and the macroeconomic environment remains uncertain due to ...

Johnson & Johnson submitted a supplemental Biologics License Application to expand Stelara’s use to children aged two years ...

Big Pharma sees Chinese pharma and biotech companies as increasingly attractive to do deals with as the quality of work ...

For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between segments. But a pair of ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...